Current Atherosclerosis Reports

, Volume 8, Issue 6, pp 460–465 | Cite as

The effects of macronutrients on blood pressure and lipids: An overview of the DASH and omniheart trials

  • Edgar R. MillerIIIEmail author
  • Thomas P. Erlinger
  • Lawrence J. Appel


Macronutrients are those nutrients (protein, fat, and carbohydrate) that provide energy. The purpose of this review is to highlight findings of three large-scale, isocaloric feeding studies: the Dietary Approaches to Stop Hypertension (DASH) trial, the DASH-Sodium trial, and the Optimal Macro-Nutrient Intake to Prevent Heart Disease (OmniHeart) trial. Each of these trials tested the effects of diets with different macronturient profiles on traditional cardiovascular disease (CVD) risk factors (ie, blood pressure and blood lipids) in the setting of stable weight. The DASH and DASH-sodium trials demonstrated that a carbohydrate-rich diet that emphasizes fruits, vegetables, and low-fat dairy products and that is reduced in saturated fat, total fat, and cholesterol substantially lowered blood pressure and low-density lipoprotein cholesterol. OmniHeart demonstrated that partial replacement of carbohydrate with either protein (about half from plant sources) or with unsaturated fat (mostly monounsaturated fat) can further reduce blood pressure, low-density lipoprotein cholesterol, and coronary heart disease risk. Results from these trials highlight the importance of macronutrients as a determinant of CVD risk. Furthermore, these results also document substantial flexibility that should enhance the ability of individuals to consume a heart-healthy diet.


Dietary Pattern Control Feeding Study UNSAT Diet Carb Diet 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Keys A: Coronary Heart Disease in Seven Countries. New York: American Heart Association Monograph; 1970, Number 29.Google Scholar
  2. 2.
    Appel LJ, Sacks FM, Carey V, et al.: The effect of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005, 294:2455–2464.PubMedCrossRefGoogle Scholar
  3. 3.
    Appel LJ, Moore TJ, Obarzanek E, et al., for the DASH Collaborative Research Group: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997, 336:1117–1124.PubMedCrossRefGoogle Scholar
  4. 4.
    Sacks FM, Svetkey LP, Volmer WM, et al., for the DASH-sodium Collaborative Research Group: A clinical trial of the effects on blood pressure of reduced dietary sodium and the DASH dietary pattern (The DASH-sodium Trial). N Engl J Med 2001, 344:3–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhou BF, Stamler J, Dennis B, et al., for the INTERMAP Research Group: Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990’s: The INTERMAP study. J Hum Hypertens 2003, 17:623–630.PubMedCrossRefGoogle Scholar
  6. 6.
    Conlin PR, Chow DC, Miller ER III, et al.: The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Hypertens 2000, 13:949–955.PubMedCrossRefGoogle Scholar
  7. 7.
    Appel LJ, Miller III ER, Jee SH, et al.: Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000, 102:852–857.PubMedGoogle Scholar
  8. 8.
    Obarzanek E, Sacks FM, Vollmer WM, et al.: Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001, 74:80–89.PubMedGoogle Scholar
  9. 9.
    Harsha DW, Sacks FM, Obarzanek E, et al.: Effect of sodium reduction and the DASH diet on blood lipids. Hypertension 2004, 43(part 2):393–398.PubMedCrossRefGoogle Scholar
  10. 10.
    Yokoyama M: JELIS-Japan Eicosapentaenoic acid (EPA) Lipid Intervention Study. Presented at the American Heart Association 2005 Scientific Sessions. November 13–16, 2005, Dallas, TX.Google Scholar
  11. 11.
    GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico): Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354:447–455.CrossRefGoogle Scholar
  12. 12.
    Balk E, Chung M, Lichtenstein A, et al.: Effects of Omega-3 Fatty Acids on Cardiovascular Disease Risk Factors and Intermediate Markers of Cardiovascular Disease. EPC report No.93, AHRQ report no 04-E010-2. Rockville, MD: Agency for Healthcare Research and Quality.Google Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • Edgar R. MillerIII
    • 1
    Email author
  • Thomas P. Erlinger
  • Lawrence J. Appel
  1. 1.National Institute on Aging, National Institutes of HealthBaltimoreUSA

Personalised recommendations